Delivery Order SPE2DB22D1041-SPE2DB23FTXW7
Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $9.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $4,593.00 delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for Janumet 50-1,000 mg tablets, a pharmaceutical product used to manage diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,212.44 for the supply of JANUMET 50-1,000 MG TABLET 180S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 29, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,530.50 for JANUMET 50-1,000 MG TABLET 180S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on March 10, 2022, with a completion date of March 11, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,915.88 for the pharmaceutical product Janumet 50-1,000 mg tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 27, 2023. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at up to $999,999,999.00. The contract is for the delivery of 4554556197 - JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The award has a ceiling value of $1,057.04 and an ultimate completion date of August 26, 2021. This contract was awarded on a full and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $16,130.85 for the supply of Janumet 50-1,000 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency responsible for providing medical supplies to the U.S. military. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $28,069.81, is a delivery order for the pharmaceutical product JANUMET 50-1,000 MG TABLET 180S. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00, which runs through December 2025. The IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,097.44 firm fixed-price delivery order is for 180 units of the pharmaceutical product Janumet 50-1,000 mg tablet. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
- This federal contract award, valued at $45,984.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of December 29, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award, valued at $5,615.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order for the supply of Janumet 50-1,000 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB23FTXW7Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $9,543.06 Delivery Order under the Defense Logistics Agency's (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a performance period through September 27, 2023. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Generated 5/12/25, 9:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 9/26/23 |